© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Regnum Corp. (RGMP) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 15, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 11, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 08, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 04, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 02, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 26, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 22, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 600 |
| Aug 15, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 12, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 11, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 08, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 06, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 05, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 04, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Jul 31, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Jul 30, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Jul 29, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Jul 28, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 600 |
| Jul 25, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York.
| Employees | 1 |
| Beta | -0.8 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Communication Services |
| Industry | Entertainment |